Ligand validation:4B84

P3G: 3,6,9,12,15-PENTAOXAHEPTADECANE

P3G is a Ligand Of Interest in 4B84 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4B84_P3G_A_1542	61%	45%	0.096	0.967	0.6	1.5	-	-	0	0	53%	0.5294
4B84_P3G_A_1543	44%	44%	0.138	0.948	0.6	1.55	-	-	0	0	53%	0.5294
4B84_P3G_A_1545	37%	48%	0.15	0.962	0.55	1.42	-	-	0	0	35%	0.3529
4B84_P3G_B_1542	18%	44%	0.193	0.883	0.53	1.6	-	1	0	0	41%	0.4118
2GYV_P3G_B_546	8%	87%	0.264	0.84	0.55	0.16	-	-	1	0	41%	0.4118
4RU0_P3G_A_501	93%	88%	0.048	0.986	0.3	0.37	-	-	0	0	76%	0.7647
6LRP_P3G_A_502	65%	83%	0.12	0.92	0.43	0.35	-	-	0	0	100%	1
6EKP_P3G_A_202	52%	82%	0.133	0.911	0.5	0.3	-	-	9	0	88%	0.8824
7V4O_P3G_A_201	38%	58%	0.147	0.85	0.65	0.96	-	1	2	0	100%	1
9IT1_P3G_A_201	38%	79%	0.187	0.89	0.57	0.31	-	-	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.